Request Demo
Last update 20 Mar 2025
TAA6-CAR-T(PersonGen BioTherapeutics)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Universal CAR-T |
Synonyms |
Target |
Action inhibitors |
Mechanism CD276 inhibitors(CD276 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationRare Pediatric Disease (United States), Orphan Drug (United States) |
Login to view timeline
Related
4
Clinical Trials associated with TAA6-CAR-T(PersonGen BioTherapeutics)CTR20222451
TAA06注射液治疗复发/难治神经母细胞瘤患者的开放标签、剂量递增、剂量扩展的I期临床研究
[Translation] An open-label, dose-escalation, and dose-expansion phase I clinical study of TAA06 injection in patients with relapsed/refractory neuroblastoma
NCT05562024
An Open-label, Dose-escalation, and Dose-expansion Phase I Trial of TAA06 Injection in Patients With Relapsed/Refractory Neuroblastoma
ChiCTR2200055199
Clinical study of TAA06 injection in the treatment of advanced solid tumor
100 Clinical Results associated with TAA6-CAR-T(PersonGen BioTherapeutics)
Login to view more data
100 Translational Medicine associated with TAA6-CAR-T(PersonGen BioTherapeutics)
Login to view more data
100 Patents (Medical) associated with TAA6-CAR-T(PersonGen BioTherapeutics)
Login to view more data
100 Deals associated with TAA6-CAR-T(PersonGen BioTherapeutics)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroblastoma recurrent | Phase 1 | China | 30 Dec 2022 | |
| Refractory Neuroblastoma | Phase 1 | China | 30 Dec 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 01 Jun 2021 | |
| Colorectal Cancer | Phase 1 | China | 01 Jun 2021 | |
| Lung Cancer | Phase 1 | China | 01 Jun 2021 | |
| Melanoma | Phase 1 | China | 01 Jun 2021 | |
| Pancreatic Cancer | IND Application | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free